| human | Q5 |
| P496 | ORCID iD | 0000-0002-1262-9987 |
| P106 | occupation | researcher | Q1650915 |
| Q59333542 | 1105. Vibriocidal Titer Variation and Likelihood of Protection in Children Compared With Adults in a Cholera Endemic Area |
| Q59327733 | 622. Increased IgA Coating of Gut Microbes After Administration of Killed, Whole-Cell Oral Cholera Vaccine |
| Q37358603 | A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh |
| Q50043320 | Analysis of the Human Mucosal Response to Cholera Reveals Sustained Activation of Innate Immune Signaling Pathways |
| Q37252335 | Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh |
| Q35164830 | Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers |
| Q37333494 | Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh |
| Q37721929 | Antigen-specific memory B-cell responses to enterotoxigenic Escherichia coli infection in Bangladeshi adults |
| Q92264656 | Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccine |
| Q34281570 | Bacterial shedding in household contacts of cholera patients in Dhaka, Bangladesh |
| Q24536068 | Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity |
| Q89999663 | Can Cholera "Hotspots" be Converted to Cholera "Coldspots" in Cholera Endemic Countries? The Matlab, Bangladesh Experience |
| Q37191414 | Cholera caused by Vibrio cholerae O1 induces T-cell responses in the circulation |
| Q36793894 | Cholera in pregnancy: Clinical and immunological aspects |
| Q37358547 | Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. |
| Q34075150 | Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses |
| Q37440466 | Clinical outcomes in household contacts of patients with cholera in Bangladesh |
| Q90721130 | Cognate T and B cell interaction and association of follicular helper T cells with B cell responses in Vibrio cholerae O1 infected Bangladeshi adults |
| Q35098194 | Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera |
| Q37206031 | Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1. |
| Q35138801 | Comparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh |
| Q36277234 | Complexity of rice-water stool from patients with Vibrio cholerae plays a role in the transmission of infectious diarrhea |
| Q33826000 | Concomitant enterotoxigenic Escherichia coli infection induces increased immune responses to Vibrio cholerae O1 antigens in patients with cholera in Bangladesh |
| Q40145989 | Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh |
| Q57929320 | Defining endemic cholera at three levels of spatiotemporal resolution within Bangladesh |
| Q33557811 | Development of immunoglobulin M memory to both a T-cell-independent and a T-cell-dependent antigen following infection with Vibrio cholerae O1 in Bangladesh |
| Q35677463 | Diarrheal Illness and Healthcare Seeking Behavior among a Population at High Risk for Diarrhea in Dhaka, Bangladesh |
| Q35112553 | Diarrheal epidemics in Dhaka, Bangladesh, during three consecutive floods: 1988, 1998, and 2004. |
| Q40371673 | Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh |
| Q52650640 | Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial. |
| Q57929912 | Emergency deployment of oral cholera vaccine for the Rohingya in Bangladesh |
| Q36022039 | Enterotoxigenic Escherichia coli and Vibrio cholerae diarrhea, Bangladesh, 2004. |
| Q62651292 | Estimating cholera incidence with cross-sectional serology |
| Q40295575 | Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial |
| Q57927158 | Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh |
| Q36450674 | Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh |
| Q34549663 | Household Transmission of Vibrio cholerae in Bangladesh |
| Q57930447 | Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection |
| Q33588522 | Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera |
| Q33424453 | Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh |
| Q39686671 | Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh |
| Q34117960 | Individuals with Le(a+b-) blood group have increased susceptibility to symptomatic vibrio cholerae O1 infection |
| Q92339950 | Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh |
| Q57931868 | Memory B Cell and Other Immune Responses in Children Receiving Two Doses of an Oral Killed Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh |
| Q35940653 | Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh |
| Q34269661 | Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh |
| Q37410387 | Memory T-cell responses to Vibrio cholerae O1 infection |
| Q34739071 | Mucosal immunologic responses in cholera patients in Bangladesh |
| Q36881533 | O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh |
| Q91030324 | Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh |
| Q64130108 | Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh |
| Q40189342 | Plasma and Mucosal Immunoglobulin M, Immunoglobulin A, and Immunoglobulin G Responses to the Vibrio cholerae O1 Protein Immunome in Adults With Cholera in Bangladesh |
| Q52717464 | Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh. |
| Q92756121 | Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae |
| Q96946565 | Predicting Vibrio cholerae infection and disease severity using metagenomics in a prospective cohort study |
| Q126110811 | Promised and Lottery Airtime Incentives to Improve Interactive Voice Response Survey Participation Among Adults in Bangladesh and Uganda: Randomized Controlled Trial |
| Q98508243 | Protection conferred by typhoid fever against recurrent typhoid fever in urban Kolkata |
| Q90686521 | Re-evaluating herd protection by Vi typhoid vaccine in a cluster randomized trial |
| Q34119165 | Relatedness of Vibrio cholerae O1/O139 isolates from patients and their household contacts, determined by multilocus variable-number tandem-repeat analysis |
| Q39708963 | Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. |
| Q64054143 | Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: evidence from a randomized placebo-controlled trial |
| Q37686863 | Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh |
| Q37358533 | Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during floods in 1998, 2004, and 2007 in Dhaka, Bangladesh. |
| Q37530434 | Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells |
| Q33327386 | Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh |
| Q36338530 | The increased severity in patients presenting to hospital with diarrhea in Dhaka, Bangladesh since the emergence of the hybrid strain of Vibrio cholerae O1 is not unique to cholera patients |
| Q36445329 | The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139. |
| Q57932840 | The oral cholera vaccine Shanchol™ when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants |
| Q42957120 | Transcriptional profiling of Vibrio cholerae recovered directly from patient specimens during early and late stages of human infection |
| Q64982832 | Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial. |
| Q96689995 | Use of Typhoid Vi-Polysaccharide Vaccine as a Vaccine Probe to Delineate Clinical Criteria for Typhoid Fever |
| Q64095027 | Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera |
| Q47564692 | Vibrio cholerae genomic diversity within and between patients |
| Q58339109 | Vibrio cholerae genomic diversity within and between patients |
| Q64228162 | Vibriocidal Titer and Protection From Cholera in Children |
Search more.